Kingdomway(SZ:002626)2026-01-29 12:30Group 1: Market Outlook and Product Expansion - The coenzyme Q10 market has a broad outlook, expanding from the initial target group of individuals aged 65 and above and heart disease patients to include statin users, working professionals, and athletes. Demand in overseas markets remains stable, while domestic and emerging market demand is gradually being released [2]. - The company plans to expand its production capacity based on market demand assessments and its own advantages, ensuring a leading industry position and market share [2]. - The company’s 10,000-ton oil project will produce algae oil Omega-3, DHA, and ARA, utilizing microbial fermentation technology for efficient and scalable production, which is environmentally friendly and aligns with ESG principles [3]. Group 2: Raw Material and Product Development - The company maintains R&D investments in leading products like coenzyme Q10, continuously improving technology and processes to ensure cost leadership and product quality [3]. - New market opportunities are being explored to diversify product offerings, including algae oil Omega-3, yeast protein, and biological sweeteners [3]. - The yeast protein business is gaining attention for its high nutritional value and sustainability, with plans for further R&D and production [4]. Group 3: Nutritional Supplements and Market Strategy - The company’s nutritional supplement factory in the U.S. has overcome previous losses and is expanding production capacity and product lines, including soft capsules, to meet brand demands and increase profitability [5]. - Increased regulatory scrutiny on cross-border health products is expected to eliminate low-quality products, creating a fair market environment for compliant companies [6]. - The brand strategy for 2026 focuses on expanding market share and enhancing brand influence through increased marketing investment and optimized product channels [6][7].